Right Ventricular Response to Exercise Among Patients With Chronic Obstructive Pulmonary Disease
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Exercise training.
- Who it may be relevant to
- Registry conditions: COPD, Pulmonary Hypertension, Exercise, Right Ventricular (RV) Dysfunction. Basic parameters: from 40 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Phenotyping Resting and Exertional Right Ventricular Dysfunction Among Patients With Chronic Obstructive Pulmonary Disease
Overview
This study plans to learn more about heart function among individuals with chronic obstructive pulmonary disease (COPD). In particular, the investigators want to understand the different patterns of right ventricular response during rest and moderate- vs high-intensity exercise. By identifying patterns of right ventricular dysfunction, this study will help identify better treatments for patients with COPD in the future.
Detailed description
This study will determine patterns of right ventricular (RV) response to aerobic exercise in patients with chronic obstructive pulmonary disease (COPD) and will design a targeted exercise intervention to improve RV response. We will study 60 patients with COPD. Participants will complete cardiopulmonary exercise testing (CPET) and transthoracic echocardiography (TTE) during rest, moderate- and high-intensity exercise. A subset of participants (n=16) who have been recommended to undergo clinical right heart catheterization will be recruited for the primary study with additional invasive pressure-volume analysis during the CPET. This testing will be used to validate measures of RV function obtained through noninvasive testing. The sample size was selected based upon our preliminary data and statistical analysis plans.
To test whether an exercise intervention targeted to RV response to exercise is feasible for patients, 12 participants will complete a targeted exercise training intervention based on their RV contractile response during baseline testing. This intervention will include participants who demonstrate RV contractility increase to moderate- but not high-intensity exercise. We will test the feasibility of a moderate-intensity interval training program. Participants will complete exercise training sessions 3x/week for 12 weeks. Exercise training will be performed on an upright stationary bicycle. Following the exercise training intervention, participants will repeat CPET and TTE. They will also complete a health-related quality of life questionnaire before and after the exercise training intervention.
Interventions
- Behavioral Exercise training
Exercise training will include moderate-intensity interval training 3x/week.
Primary outcome measures
- Right ventricular contractility measured by transthoracic echocardiography [Time frame: Up to 1 hour]
Secondary outcome measures (7)
- Right ventricular contractility measured by conductance catheter [Time frame: Up to 1 hour]
- Right ventricular systolic function measured by transthoracic echocardiography [Time frame: Up to 1 hour]
- Right ventricular systolic function measured by transthoracic echocardiography [Time frame: Up to 1 hour]
- Exercise training feasibility [Time frame: 4 months]
- Exercise training safety [Time frame: 4 months]
- Health-related quality of life by Short Form 36 (SF-36) questionnaire [Time frame: Up to 1 hour]
- Maximum oxygen consumption (VO2max) [Time frame: Up to 1 hour]
Eligibility criteria
Inclusion criteria
- COPD (determined by ratio of forced expiratory volume in 1 second to forced vital capacity \[FEV1/FVC\] <0.7)
- Age >= 40 years
Exclusion criteria
- Exacerbation of COPD in the 3 months prior to enrollment
- Change in COPD therapy in the 3 weeks prior to enrollment
- Requirement of >6 LPM supplemental oxygen at rest
- Requirement of >10 LPM supplemental oxygen with exertion
- Active/uncontrolled cardiovascular disease (e.g. hypertension with blood pressure >150/100 despite antihypertensives; coronary artery disease with angina; left ventricular ejection fraction ≤40%; uncontrolled arrhythmia; pulmonic, mitral or aortic valvular abnormality greater than mild in severity; tricuspid regurgitation greater than moderate in severity)
- Volume overload (jugular vascular distension or greater than trace peripheral edema)
- World Health Organization Functional Class IV
- Known pulmonary hypertension with mean pulmonary artery pressure >45 mmHg
- Untreated severe obstructive sleep apnea and/or obesity hypoventilation syndrome
- Active malignancy (other than skin)
- Medical conditions that limit exercise on an upright stationary bicycle (e.g. severe osteoarthritis, imbalance/gait instability, etc.)
- Pregnancy
- Body mass index <18 or >35
- Hematocrit <25% or >55%
- For subset undergoing right heart catheterization, chronic anticoagulation that is unable to be held for the study visit
- For subset undergoing right heart catheterization or exercise training, forced expiratory volume in 1 second of <20%
- For exercise training, already engaged in routine exercise training (>30 minutes at >3 METs 3 times/week or more)
- For exercise training, inability to complete initial in-person exercise training sessions for approximately 35 minutes 3x/week for 3 weeks (followed by exercise training sessions with an option for hybrid remote/in-person participation)
- For exercise training with an option for hybrid remote exercise training, any medical conditions which threaten the safety of remote exercise training (e.g. imbalance/gait instability, etc.).
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
United States · 1 center
- University of Colorado Anschutz Medical Campus — Aurora
Identifiers
NCT: NCT07576894 · 23-0516b · K23HL175186